Related Experiment Video
Updated: Jun 22, 2026
06:24
Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
Gender effects on cardiac valvular function in hyperprolactinaemic patients receiving cabergoline: a retrospective
Lisa B Nachtigall1, Elena Valassi, Janet Lo
1Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. lnachtigall@partners.org
Clinical Endocrinology
|June 11, 2009
Summary
Cabergoline, used for hyperprolactinaemia, did not show overall valvulopathy risk. However, mild tricuspid regurgitation was more common in female patients and trace regurgitation in male patients compared to controls.
Area of Science:
- Endocrinology
- Cardiology
- Pharmacology
Background:
- Ergot-derived dopamine agonists are linked to valvular dysfunction in Parkinson's disease.
- The valvular disease risk of cabergoline for prolactinomas is debated.
Purpose of the Study:
- To investigate the association between cabergoline use and valvular function in hyperprolactinaemia patients, examining gender-specific effects.
Main Methods:
- Retrospective case-record study involving 100 hyperprolactinaemia patients on cabergoline and 100 matched controls.
- Echocardiograms were used to assess valvular function.
Main Results:
- No significant overall differences in valvular function between patients and controls.
- Women patients showed a higher prevalence of mild tricuspid regurgitation (TR) (15.4% vs. 1.9%).
- Men patients exhibited a higher prevalence of trace TR (68.8% vs. 45.8%).
Conclusions:
- Cabergoline was not associated with valvulopathy overall.
- Gender-specific differences in TR prevalence were observed, suggesting potential gender-based effects.
- Further research is needed to confirm cabergoline's long-term impact on valvular function in hyperprolactinaemia.
Related Concept Videos
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...